What is the Impact Factor of Therapeutic Advances in Drug Safety?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Therapeutic Advances in Drug Safety is 3.30, ranking in quartile Q2 of Web of Science (SCIE).

Is Therapeutic Advances in Drug Safety indexed in Web of Science or Scopus?

Yes, Therapeutic Advances in Drug Safety is indexed in Web of Science (SCIE, Q2 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.833 (Q2) and an H-index of 55.

Who publishes Therapeutic Advances in Drug Safety and what is the Article Processing Charge (APC)?

Therapeutic Advances in Drug Safety is published by SAGE. The estimated Article Processing Charge (APC) is approximately $3,276 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Therapeutic Advances in Drug Safety?

The official ISO-4 abbreviation of Therapeutic Advances in Drug Safety is "THER ADV DRUG SAF". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q2Scopus Q2SCImago #6,508Gold OA

Therapeutic Advances in Drug Safety

Abbreviation (ISO):THER ADV DRUG SAF

•

Identifier (ISSN):2042-0986(Print)/2042-0994(Online)

•

Publisher:SAGE

Official Website Submission Portal Compare

Clarivate IF (2026)

3.3↓ -0.1

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2020–2026)

Clarivate IF trend for Therapeutic Advances in Drug Safety

WoS Q2

Annual Impact Factor Metric

Current (2026):3.3

Scopus SJR & RankScopus Q2

0.833

#6,508

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

55 papers with at least that number of citations each

WoS: SCIE / JCRQ2

Self-Citation Rate5.9%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessGold OA

34articles/year

100% Gold OA•66.67% Original Research

Aims & Scope

Therapeutic Advances in Drug Safety delivers the highest quality peer-reviewed articles, reviews, and scholarly comment on pioneering efforts and innovative studies pertaining to the safe use of drugs in patients. The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers in drug safety, providing a forum in print and online for publishing the highest quality articles in this area. The editors welcome articles of current interest on research across all areas of drug safety, including therapeutic drug monitoring, pharmacoepidemiology, adverse drug reactions, drug interactions, pharmacokinetics, pharmacovigilance, medication/prescribing errors, risk management, ethics and regulation.

Topics Covered (Recognized by AI)

Medicine99.5%Biology87.7%Internal medicine84.5%Pharmacology68.6%Psychology65.8%Psychiatry61.7%Pathology51.8%Intensive care medicine43%Adverse effect35.9%Chemistry33.4%Surgery30.7%Political science30.2%Law29.7%Nursing29.2%Mathematics29%Drug28.5%Biochemistry27.5%Statistics26.8%Economics26.3%Genetics25.8%Family medicine25.6%Endocrinology23.3%

Primary Research Areas

Medicine Pharmacology (medical)

Official Website NLM PubMed Catalog SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

PHARMACOLOGY & PHARMACY

Rank149/356

IndexSCIE

JCISCIE2026

PHARMACOLOGY & PHARMACY

Rank135/356

IndexSCIE

Category	Index	Rank	Quartile
PHARMACOLOGY & PHARMACY	JCRSCIE	149/356	Q2
PHARMACOLOGY & PHARMACY	JCISCIE	135/356	Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF3.3

Articles / Year52

Total Citations29

2025

IF3.4

Articles / Year68

Total Citations266

2024

IF3.4

Articles / Year51

Total Citations323

2023

IF4.4

Articles / Year28

Total Citations277

2022

IF3.216

Articles / Year35

Total Citations657

Year	Impact Factor	Articles / Year	Total Citations
2026	3.3	52	29
2025	3.4	68	266
2024	3.4	51	323
2023	4.4	28	277
2022	3.216	35	657
2021	3.842	38	712
2020	3.463	35	1,379
2019	—	52	1,280
2018	—	51	1,860
2017	—	35	1,574
2016	—	32	1,073
2015	—	29	1,277

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #6,508Scopus Q2SCImago Profile

Scopus Coverage:2010-2026

•

Scopus Broad Areas:Medicine

Scopus Citation Rank (SJR)Q2

0.833

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2

Citations / Doc (2 years)

2.96

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,276 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations366

3-Year Documents110

Citable Documents102

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate48.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Pharmacology (medical)Q2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 5.9%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

2区 (Zone 2)Medicine

Minor Category (Specific Field):

2区PHARMACOLOGY & PHARMACY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Therapeutic Advances in Drug Safety (abbr: THER ADV DRUG SAF, ISSN: 2042-0986) is a peer-reviewed international scholarly journal in the field of Medicine, published by SAGE in England. The periodical holds a Journal Impact Factor (JIF) of 3.30, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.833 (Q2), an H-index of 55.

The journal enforces rigorous peer evaluation with an annual output of approximately 34 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,276 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.